Agoraphobia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
Conditions:   Generalized Anxiety Disorder;   Social Anxiety Disorder;   Panic Disorder;   Agoraphobia Interventions:   Drug: 50:2 mg(CBD:THC)/ml - Cannabinoid Oil Oral Preparation- titrated as tolerated up to a maximum 8mls twice daily (200 mg- 800 mg total dose);   Drug: Placebo Oil Sponsors:   McMaster University;   MediPharm Labs Corp Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 30, 2020 Category: Research Source Type: clinical trials